Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
5
×
life sciences
national blog main
startups
vc
5
×
boston
deals
national top stories
san francisco blog main
biotech
new york blog main
software
healthcare
new york top stories
san diego blog main
san francisco top stories
seattle blog main
venture capital
acetylon pharmaceuticals
amazon
ambys medicines
american well
andreessen horowitz
apple
arrowmark partners
athenahealth
azacitidine
barack obama
beta bionics
beta-thalassemia
bigfoot biomedical
bill frist
boston children's hospital
boston university
castlight health
cell therapy
circulation
clinical trials
congenital hyperinsulinism
What
startup
5
×
approach
biotech
called
developing
healthcare
make
medical
medicines
million
new
acquisition
aiming
aims
amazon’s
ambys
andreessen
answer
based
beta
big
bionics
blood
ceo
circulation
closed
control
deadly
deal
debuted
debuts
device
devoted
diabetes
diseases
driven
drugs
efficient
emergency
epigenetic
Language
unset
Current search:
startup
×
vc
×
" boston top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?